Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China flag China · Delayed Price · Currency is CNY
16.07
-0.65 (-3.89%)
Jun 4, 2026, 3:04 PM CST
Market Cap7.77B -23.2%
Revenue (ttm)1.87B -37.8%
Net Income-167.76M
EPS-0.35
Shares Out 464.53M
PE Ration/a
Forward PE18.58
Dividend0.22 (1.26%)
Ex-Dividend DateJun 2, 2026
Volume6,422,912
Open17.69
Previous Close16.72
Day's Range16.00 - 17.69
52-Week Range16.02 - 26.29
Beta0.91
AnalystsStrong Buy
Price Target26.79 (+66.71%)
Earnings DateAug 19, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney... [Read more]

Sector Healthcare
Founded 1992
Employees 2,443
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300482
Full Company Profile

Financial Performance

Financial Statements